What is the starting dose for an epinephrine (adrenaline) drip in adults with severe allergic reactions or anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epinephrine Drip Dosing for Severe Allergic Reactions/Anaphylaxis

For adults with severe allergic reactions or anaphylaxis, the recommended starting dose for an epinephrine drip is 1-4 mcg/min, which can be titrated up to a maximum of 10 mcg/min based on clinical response and side effects. 1

Preparation Methods for Epinephrine Infusions

There are two standard methods to prepare an epinephrine infusion for adults:

Method 1: Standard Concentration

  • Add 1 mg (1 mL) of 1:1000 epinephrine to 250 mL of D5W to yield a concentration of 4.0 mcg/mL 1
  • Initial infusion rate: 1-4 mcg/min (15-60 drops/min with microdrop apparatus) 1
  • Can be titrated up to maximum of 10 mcg/min based on clinical response 1

Method 2: Alternative Concentration (with Infusion Pump)

  • Add 1 mg (1 mL) of 1:1000 epinephrine to 100 mL of saline to create a 1:100,000 solution 1
  • Initial infusion rate: 30-100 mL/hr (5-15 mcg/min) 1
  • Titrate up or down based on clinical response or epinephrine side effects 1

Important Considerations and Precautions

Indications for IV Epinephrine

  • IV epinephrine should only be administered in specific circumstances: 1
    • Cardiac arrest
    • Profound hypotension unresponsive to IV fluids and IM epinephrine
    • Failure to respond to several injected doses of epinephrine

Monitoring Requirements

  • Continuous hemodynamic monitoring is essential when administering IV epinephrine 1
  • In settings without hemodynamic monitoring, use available means: 1
    • Every-minute blood pressure measurements
    • Continuous pulse monitoring
    • ECG monitoring if available

Clinical Efficacy

  • In clinical studies, most patients (18/19) with anaphylaxis showed symptomatic improvement and systolic BP >90 mmHg within 5 minutes of epinephrine infusion 1

Pediatric Dosing

  • For children, the recommended dose is 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution; maximum 0.3 mg) 1
  • Alternative pediatric dosing using "rule of 6": 0.6 × body weight (kg) = mg diluted to total 100 mL saline; then 1 mL/hr delivers 0.1 mcg/kg/min 1

Potential Adverse Effects

  • Tachyarrhythmias/ectopic beats 1
  • Hypertension 1
  • Risk of potentially lethal arrhythmias (reason for restricted use) 1
  • Extravasation can cause severe skin injury 1

First-Line Treatment Before Drip Consideration

  • IM epinephrine (0.01 mg/kg of 1:1000 solution, max 0.3-0.5 mg) is the first-line treatment for anaphylaxis 1, 2
  • IM injections should be administered in the lateral thigh (vastus lateralis) 1, 3
  • Additional IM doses can be given every 5-15 minutes if symptoms persist 1, 4
  • IV epinephrine infusion should only be considered after failure of IM epinephrine and volume resuscitation 1

Common Pitfalls to Avoid

  • Delaying epinephrine administration (increases mortality risk) 5, 4
  • Using subcutaneous instead of intramuscular route (delayed onset of action) 5
  • Starting with IV epinephrine before trying IM epinephrine (increased risk of adverse effects) 1
  • Relying on antihistamines or corticosteroids as first-line treatment (they are adjunctive only) 1, 4
  • Inadequate monitoring during epinephrine infusion 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The role of epinephrine in the treatment of anaphylaxis.

Current allergy and asthma reports, 2003

Research

Epinephrine in the Management of Anaphylaxis.

The journal of allergy and clinical immunology. In practice, 2020

Research

Epinephrine (adrenaline) in anaphylaxis.

Chemical immunology and allergy, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.